Global Epilepsy Market : Industry Analysis & Outlook ( 2017-2021 ) Epilepsy is a group of neurological diseases characterized by epileptic seizures . Epileptic seizures are episodes that can vary from brief and nearly undetectable to long periods of vigorous shaking . These episodes can result in physical injuries including occasionally broken bones . The medical definition of this disease is as a “ condition characterized by recurrent ( two or more ) epileptic seizures , unprovoked by any immediate identified cause ”. Epilepsy is divided into four main types ; idiopathic generalized epilepsy , idiopathic partial epilepsy , symptomatic generalized epilepsy and symptomatic partial epilepsy . The cause of epilepsy can be genetic , a result of other disorders such as tumor or brain injury and due to certain seizure triggers .
Global Epilepsy Market : Industry Analysis & Outlook ( 2017-2021 ) Epilepsy is a group of neurological diseases characterized by epileptic seizures . Epileptic seizures are episodes that can vary from brief and nearly undetectable to long periods of vigorous shaking . These episodes can result in physical injuries including occasionally broken bones . The medical definition of this disease is as a “ condition characterized by recurrent ( two or more ) epileptic seizures , unprovoked by any immediate identified cause ”. Epilepsy is divided into four main types ; idiopathic generalized epilepsy , idiopathic partial epilepsy , symptomatic generalized epilepsy and symptomatic partial epilepsy . The cause of epilepsy can be genetic , a result of other disorders such as tumor or brain injury and due to certain seizure triggers .
Epilepsy is treated via antiepileptic drugs , surgery in certain cases and several complementary therapies such as ketogenic diets or neural stimulation . Based upon the drug type , epilepsy market can be divided into three main categories ; first generation drugs , second generation drugs and third generation drugs .
The global epilepsy market is driven by factors such as development of novel drugs , launch of new drugs in developing regions and prevalence of neural disorders such as meningitis and tumors . This growth is then further spearheaded by increasing healthcare expenses and rising disposable incomes . However , the market growth is hindered by tedious drug approval process , generic erosion and high cost of treatment . Trends such as companies focusing on developing effective therapies for refractory epilepsy and physicians demanding higher efficacy drugs are listed in this report .
Place a direct purchase order on this “ Epilepsy Drugs Market ” research report at USD 800 ( Single User License ) http :// www . marketreportsonline . com / contacts / purchase . php ? name = 574913 .